Center-Authored Papers

Filters: Author is Tewari, Muneesh  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Virus Integration
Knouf EC, Metzger MJ, Mitchell PS, Arroyo JD, Chevillet JR, Tewari M, Miller AD.  2009.  Multiple integrated copies and high-level production of the human retrovirus XMRV (xenotropic murine leukemia virus-related virus) from 22Rv1 prostate carcinoma cells.. Journal of virology. 83(14):7353-6. Abstract
Vaccine and Infectious Disease Division
Vojtech L, Woo S, Hughes S, Levy C, Ballweber L, Sauteraud RP, Strobl J, Westerberg K, Gottardo R, Tewari M et al..  2014.  Exosomes in human semen carry a distinctive repertoire of small non-coding RNAs with potential regulatory functions.. Nucleic acids research. 42(11):7290-304. Abstract
Up-Regulation
Ventura AP, Radhakrishnan S, Green A, Rajaram SK, Allen AN, O'Briant K, Schummer M, Karlan B, Urban ND, Tewari M et al..  2010.  Activation of the MEK-S6 pathway in high-grade ovarian cancers.. Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry. 18(6):499-508. Abstract
Tumor Markers, Biological
Kroh EM, Parkin RK, Mitchell PS, Tewari M.  2010.  Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR).. Methods (San Diego, Calif.). 50(4):298-301. Abstract
Grady WM, Tewari M.  2010.  The next thing in prognostic molecular markers: microRNA signatures of cancer.. Gut. 59(6):706-8.
Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A et al..  2008.  Circulating microRNAs as stable blood-based markers for cancer detection.. Proceedings of the National Academy of Sciences of the United States of America. 105(30):10513-8. Abstract
Ventura AP, Radhakrishnan S, Green A, Rajaram SK, Allen AN, O'Briant K, Schummer M, Karlan B, Urban ND, Tewari M et al..  2010.  Activation of the MEK-S6 pathway in high-grade ovarian cancers.. Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry. 18(6):499-508. Abstract
Transcription, Genetic
Thurman RE, Rynes E, Humbert R, Vierstra J, Maurano MT, Haugen E, Sheffield NC, Stergachis AB, Wang H, Vernot B et al..  2012.  The accessible chromatin landscape of the human genome.. Nature. 489(7414):75-82. Abstract
Wurz K, Garcia RL, Goff BA, Mitchell PS, Lee JH, Tewari M, Swisher EM.  2010.  MiR-221 and MiR-222 alterations in sporadic ovarian carcinoma: Relationship to CDKN1B, CDKNIC and overall survival.. Genes, chromosomes & cancer. 49(7):577-84. Abstract
Pomerantz MM, Beckwith CA, Regan MM, Wyman SK, Petrovics G, Chen Y, Hawksworth DJ, Schumacher FR, Mucci L, Penney KL et al..  2009.  Evaluation of the 8q24 prostate cancer risk locus and MYC expression.. Cancer research. 69(13):5568-74. Abstract
Transcription Initiation Site
Thurman RE, Rynes E, Humbert R, Vierstra J, Maurano MT, Haugen E, Sheffield NC, Stergachis AB, Wang H, Vernot B et al..  2012.  The accessible chromatin landscape of the human genome.. Nature. 489(7414):75-82. Abstract
TRANSCRIPTION FACTORS
Bendoraite A, Knouf EC, Garg KS, Parkin RK, Kroh EM, O'Briant KC, Ventura AP, Godwin AK, Karlan BY, Drescher CW et al..  2010.  Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition.. Gynecologic oncology. 116(1):117-25. Abstract
Bar M, Wyman SK, Fritz BR, Qi J, Garg KS, Parkin RK, Kroh EM, Bendoraite A, Mitchell PS, Nelson AM et al..  2008.  MicroRNA discovery and profiling in human embryonic stem cells by deep sequencing of small RNA libraries.. Stem cells (Dayton, Ohio). 26(10):2496-505. Abstract
Thurman RE, Rynes E, Humbert R, Vierstra J, Maurano MT, Haugen E, Sheffield NC, Stergachis AB, Wang H, Vernot B et al..  2012.  The accessible chromatin landscape of the human genome.. Nature. 489(7414):75-82. Abstract
Spheroids, Cellular
Hayes B, Fagerlie SR, Ramakrishnan A, Baran S, Harkey M, Graf L, Bar M, Bendoraite A, Tewari M, Torok-Storb B.  2008.  Derivation, characterization, and in vitro differentiation of canine embryonic stem cells.. Stem cells (Dayton, Ohio). 26(2):465-73. Abstract
Specimen Processing Core Facility
Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A et al..  2008.  Circulating microRNAs as stable blood-based markers for cancer detection.. Proceedings of the National Academy of Sciences of the United States of America. 105(30):10513-8. Abstract
Signal Transduction
Ventura AP, Radhakrishnan S, Green A, Rajaram SK, Allen AN, O'Briant K, Schummer M, Karlan B, Urban ND, Tewari M et al..  2010.  Activation of the MEK-S6 pathway in high-grade ovarian cancers.. Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry. 18(6):499-508. Abstract
Shared Resources
Chevillet JR, Kang Q, Ruf IK, Briggs HA, Vojtech LN, Hughes SM, Cheng HH, Arroyo JD, Meredith EK, Gallichotte EN et al..  2014.  Quantitative and stoichiometric analysis of the microRNA content of exosomes.. Proceedings of the National Academy of Sciences of the United States of America. 111(41):14888-93. Abstract
Grady WM, Parkin RK, Mitchell PS, Lee JH, Kim Y-H, Tsuchiya KD, Washington MK, Paraskeva C, Willson JKV, Kaz AM et al..  2008.  Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer.. Oncogene. 27(27):3880-8. Abstract
Pomerantz MM, Beckwith CA, Regan MM, Wyman SK, Petrovics G, Chen Y, Hawksworth DJ, Schumacher FR, Mucci L, Penney KL et al..  2009.  Evaluation of the 8q24 prostate cancer risk locus and MYC expression.. Cancer research. 69(13):5568-74. Abstract
Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A et al..  2008.  Circulating microRNAs as stable blood-based markers for cancer detection.. Proceedings of the National Academy of Sciences of the United States of America. 105(30):10513-8. Abstract
Sarkar D, Parkin R, Wyman S, Bendoraite A, Sather C, Delrow JJ, Godwin AK, Drescher CW, Huber W, Gentleman R et al..  2009.  Quality assessment and data analysis for microRNA expression arrays.. Nucleic acids research. 37(2):e17. Abstract
Ventura AP, Radhakrishnan S, Green A, Rajaram SK, Allen AN, O'Briant K, Schummer M, Karlan B, Urban ND, Tewari M et al..  2010.  Activation of the MEK-S6 pathway in high-grade ovarian cancers.. Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry. 18(6):499-508. Abstract
Bendoraite A, Knouf EC, Garg KS, Parkin RK, Kroh EM, O'Briant KC, Ventura AP, Godwin AK, Karlan BY, Drescher CW et al..  2010.  Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition.. Gynecologic oncology. 116(1):117-25. Abstract
Wurz K, Garcia RL, Goff BA, Mitchell PS, Lee JH, Tewari M, Swisher EM.  2010.  MiR-221 and MiR-222 alterations in sporadic ovarian carcinoma: Relationship to CDKN1B, CDKNIC and overall survival.. Genes, chromosomes & cancer. 49(7):577-84. Abstract